Roberto Costillas Perez: The Endometrial Microbiome Is a Key Factor for Uterine Receptivity
Roberto Costillas Perez, Founder and CEO at Fertypharm, shared a post on LinkedIn:
“The endometrial microbiome is a key factor for reproductive health and uterine receptivity.
A balanced microbiome, dominated by Lactobacillus improves embryo implantation and reproductive success.
In contrast, microbial dysbiosis is associated with implantation failure and complications such as endometritis.
- Studies show that patients with a healthy endometrial microbiome are up to 30% more likely to have a successful pregnancy after assisted reproduction.
- In addition, the microbiome influences the immune response and gene expression of the endometrium, modulating an optimal environment for implantation.
This opens up new therapeutic opportunities to treat infertility.
The endometrial microbiome is a key factor for reproductive health and uterine receptivity.
A balanced microbiome, dominated by Lactobacillus, enhances embryo implantation and reproductive success.
In contrast, microbial dysbiosis is linked to implantation failure and complications like endometritis.
- Studies show patients with a healthy endometrial microbiome have up to a 30% higher chance of successful pregnancy after assisted reproduction.
- The microbiome influences immune responses and endometrial gene expression, creating an optimal environment for implantation.
This opens new therapeutic opportunities to treat infertility.”
Title: Endometrial Microbiome and Reproductive Receptivity: Diverse Perspectives
Authors: Galina Stoyancheva, Nikolina Mihaylova, Maria Gerginova, Ekaterina Krumova
Read the full article.
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Nov 2, 2026, 17:08Elena Milner: The 2nd Class of the School of Embryology Is Already in Full Swing
-
Nov 2, 2026, 17:05November Is National Diabetes Month – PCOS Awareness Association
-
Nov 2, 2026, 17:04Thanos Papathanasiou: Are We Preparing Patients for the IVF Cycle, or for the IVF Journey?
-
Nov 2, 2026, 17:02Anna Morales: Why Is It So Hard to Build in Women’s Health?
-
Nov 2, 2026, 16:59Rickard Ericsson: Honored to Take on the Role of Interim CEO of the Vitrolife Group
-
Nov 2, 2026, 16:56Mohammed Nasur: 1 Small Simulation, A Bigger Purpose
-
Nov 2, 2026, 16:54Carlos Guerrero: Presenting Our Latest Research on AI and Embryo Assessment at ASRM 2026
-
Nov 2, 2026, 16:52Sarah Lewen: My 1st ASRM Is Officially Complete
-
Nov 2, 2026, 16:49Jemma Garratt: Taking on the Role of Kind IVF and Data Science Manager at London Women’s Clinic